Sangamo Therapeutics Inc. buy BiotechBee
Start price
23.10.24
/
50%
€1.45
Target price
30.08.26
€2.30
Performance (%)
33.29%
End price
14.12.24
€1.93
Summary
This prediction ended on 14.12.24 with a price of €1.93. With a performance of 33.29% the BUY prediction by BiotechBee was a big success. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sangamo Therapeutics Inc. | 2.133% | 2.133% | -65.899% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% |
According to BiotechBee what are the pros and cons of Sangamo Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Sangamo Bioscienes diskutieren
Buy mit Kursziel 2,3
In the thread Trading Sangamo Bioscienes
Buy beendet

